Login

Paratek Pharmaceuticals, Inc. SEC Filings

Filed On Filing
02 Oct 2023 15-12G
25 Sep 2023 EFFECT
21 Sep 2023 Form 4: Baylor-Henry Minnie, Director

Returned 59,200 shares to the issuer · Disposed of 12,800 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 Form 4: Hoffmann Rolf K, Director

Returned 84,000 shares to the issuer · Disposed of 41,000 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 Form 4: Brenner Randall B., Chief Development & Regulatory

Returned 415,209 shares to the issuer

21 Sep 2023 Form 4: Peterson Kristine, Director

Returned 79,000 shares to the issuer · Disposed of 50,000 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 Form 4: Stein Jeffrey, Director

Returned 68,625 shares to the issuer · Disposed of 62,000 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 Form 4: Haskel William M., CLO, General Counsel & Sec.

Returned 447,024 shares to the issuer

21 Sep 2023 Form 4: Bigham Michael, Director

Received 23,255 shares by exercise or conversion ($100K) · Returned 1,358,032 shares to the issuer

21 Sep 2023 Form 4: Franson Timothy R, Director

Returned 72,000 shares to the issuer · Disposed of 62,000 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 Form 4: Woodrow Adam, President & Chief Commercial

Returned 749,034 shares to the issuer

21 Sep 2023 Form 4: Loh Evan, Director

Returned 1,327,981 shares to the issuer

21 Sep 2023 Form 4: Dietz Thomas John, Director

Returned 69,250 shares to the issuer · Disposed of 62,000 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 Form 4: Radie Robert S, Director

Returned 73,000 shares to the issuer · Disposed of 62,000 Stock option (right to buy) (Disposition to Issuer)

21 Sep 2023 SC 13E3/A
21 Sep 2023 POS AM
21 Sep 2023 S-8 POS
21 Sep 2023 S-8 POS
21 Sep 2023 S-8 POS
21 Sep 2023 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support